Compare Invesco Solar ETF (TAN) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Solar ETF vs 10X Genomics Inc — how do they compare? Invesco Solar ETF trades at $44.19 (market cap $911.39M), while 10X Genomics Inc trades at $79.5 (market cap $9.92B). The key difference: 10X Genomics Inc is far larger — about 10.9× Invesco Solar ETF's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco Solar ETF for 34 Days and 10X Genomics Inc for 92 Days on average.
| TAN | TXG | |
|---|---|---|
Market Cap | $911.39M | $9.92B |
Volume | 983,074 | 9,372,166 |
Sector | Sector/Thematic | Health |
52-Week High | $73.95 | $97.74 |
52-Week Low | $43.00 | $11.48 |
Typical Hold Time | 34 Days | 92 Days |
Enterprise Value | — | $9.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TAN (Invesco Solar ETF) trades at $43.53, down 1.96% amid sector-wide pressure from high borrowing costs impacting solar project financing. Technical indicators show a bearish trend with strong sell signals from moving averages, while oscillators remain neutral. Recent news highlights solar stocks facing headwinds from interest rate sensitivity and market saturation concerns, though long-term growth drivers from energy transition remain intact.
The ETF faces near-term challenges from financing costs and competitive pressures, but maintains strategic positioning in the growing solar energy sector. Investors should weigh volatility risks against potential policy tailwinds and increasing global renewable energy adoption for long-term growth opportunities.
10x Genomics (TXG) trades at $77.28, down 4.19% on the day, amid a bearish technical signal. The company reported revenue of $642.82M in 2025, with a net loss of $43.54M, though it has beaten EPS estimates for three consecutive quarters. Recent news highlights the launch of its Atera spatial biology platform and a patent victory, signaling innovation and market strength. Cash flow from operations improved to $136.05M in 2025, indicating better operational efficiency.
The outlook is cautiously optimistic, with strong product demand and improving margins offering upside potential. However, persistent losses, high valuation multiples, and competitive pressures present significant risks. Analyst consensus is mixed, with a $74.30 price target slightly below the current price, reflecting uncertainty about near-term profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
